Literature DB >> 15209354

Immunomodulating effects of CKBM on the cytokine production in peripheral blood mononuclear cells (PBMCs) from healthy volunteers.

B P Chan1, W F Yuen, W H Lee, S N Wong, T Y Chung, Y J Wu, S F Pang.   

Abstract

The current study investigated the immunomodulating effect of CKBM on cytokine induction in peripheral blood mononuclear cells (PBMCs) isolated from 20 healthy volunteers. Cytometric Bead Analysis (CBA) was used to study IL-2, IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma. TNF-alpha and IL-6 were significantly increased in a CKBM dose- and time-dependent manner. Flow cytometry analysis showed an increased intracellular staining of IL-6 but not of TNF-alpha in CKBM treated PBMCs. In addition, MTT cell cytotoxicity assay showed that CKBM concentrations below 5% did not significantly affect the metabolic activities of PBMCs. The current study indicated that CKBM may modulate the immune response by inducing the secretions of TNF-alpha and IL-6, which are cytokine mediators of innate immunity and inflammation preparing or "priming" the body to combat diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209354     DOI: 10.1081/iph-120037713

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  3 in total

1.  Cell Cycle Arrest by a Natural Product via G2/M Checkpoint.

Authors:  Sharon Chui-Wah Luk; Stephanie Wing-Fai Siu; Chun-Kit Lai; Ying-Jye Wu; Shiu-Fun Pang
Journal:  Int J Med Sci       Date:  2005-04-01       Impact factor: 3.738

2.  Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product.

Authors:  Wei Zhang; Edgar S L Liu; Jun Fu; Hai-Mei Tian; Ying-Jye Wu; Shiu-Fun Pang
Journal:  Invest New Drugs       Date:  2006-05       Impact factor: 3.651

3.  Anti-tumorigenic and Pro-apoptotic effects of CKBM on gastric cancer growth in nude mice.

Authors:  Vivian Yvonne Shin; Wallace Hau-Leung So; Edgar Shiu-Lam Liu; Ying-Jye Wu; Shiu-Fun Pang; Chi-Hin Cho
Journal:  Int J Med Sci       Date:  2004-08-05       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.